PaxMedica Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	12.23	8.82	4.97	4.63	0.11
Research & Development	3.91	1.79	2.22	0.94	0.48
Operating Expenses	16.15	10.6	7.2	5.57	0.6
Operating Income	-16.15	-10.6	-7.2	-5.57	-0.6
Interest Expense / Income	0.01	0.01	2.81	0.61	0
Other Expense / Income	2.14	4.19	0.23	1.65	-
Pretax Income	-18.29	-14.8	-10.23	-7.83	-0.6
Net Income	-18.29	-14.8	-10.23	-7.83	-0.6
Preferred Dividends	0	0	0	1.47	0
Net Income Common	-18.29	-14.8	-10.23	-9.3	-0.6
Shares Outstanding (Basic)	2	1	0	0	1
Shares Outstanding (Diluted)	2	1	0	0	-
Shares Change	223.37%	31.14%	15.41%	-41.39%	-
EPS (Basic)	-11.00	-28.79	-26.01	-27.37	-
EPS (Diluted)	-11.00	-28.79	-26.01	-27.37	-
Free Cash Flow	-10.77	-6.07	-5.51	-2.35	-0.42
Free Cash Flow Per Share	-6.48	-11.81	-14.06	-6.91	-0.72
EBITDA	-18.28	-14.8	-7.42	-7.22	-0.6
EBIT	-18.28	-14.8	-7.42	-7.22	-0.6

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).